| 5820 |
Centers for Disease Control and Prevention |
Html |
en |
alpha-Chloroacetophenone - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 7878 |
Centers for Disease Control and Prevention |
Html |
en |
Social Media Tools for Consumers and Partners - Twitter |
Basic information from CDC about breast cancer. |
| CDC | 0.510929 |
| brief text updates | 0.80669 |
| 140 characters | 0.595449 |
| tweets | 0.460806 |
| descriptions | 0.435231 |
| video content | 0.600691 |
| social networking Web | 0.760714 |
| safety information | 0.585305 |
| public | 0.440613 |
| variety | 0.437785 |
| micro-blogging sites | 0.749843 |
| certain audio | 0.597523 |
|
| events | 0.435178 |
| means | 0.440945 |
| online micro-blogging | 0.746518 |
| length | 0.439709 |
| text messages | 0.594342 |
| audio formats | 0.60521 |
| friends | 0.440701 |
| mobile Web sites | 0.771415 |
| Individual users | 0.58262 |
| Web site | 0.981933 |
| Twitter users | 0.695613 |
| timely health | 0.605315 |
|
CLICK HERE |
| 9049 |
Centers for Disease Control and Prevention |
Html |
en |
Leishmaniasis - Global Health |
Education and information about Leishmaniasis including fact sheets, information for special groups, prevention and control, epidemiology, diagnosis and treatment. |
| infection | 0.270084 |
| distended transparent abdomen | 0.918063 |
| typical mosquitoes | 0.57251 |
| southern Europe | 0.574166 |
| Image | 0.251529 |
| example | 0.25641 |
| different forms | 0.532095 |
| phlebotomine sand | 0.700763 |
| bite | 0.282604 |
| Neglected Tropical Disease | 0.861548 |
| flagellated promastigote stage | 0.809039 |
| DPDx | 0.295886 |
| skin sores | 0.576143 |
| blood meal | 0.526343 |
| liver | 0.266606 |
| transmit | 0.288809 |
| leishmaniasis | 0.991515 |
| Leishmania parasites | 0.737977 |
|
| cutaneous leishmaniasis | 0.980983 |
| people | 0.254408 |
| bone marrow | 0.563567 |
| sand flies | 0.73472 |
| size | 0.251018 |
| left | 0.259368 |
| tropics | 0.296988 |
| Phlebotomus papatasi | 0.578576 |
| cultures | 0.25434 |
| parts | 0.260336 |
| vector sand | 0.666525 |
| subtropics | 0.310411 |
| common forms | 0.523293 |
| visceral leishmaniasis | 0.972908 |
| parasitic disease | 0.594446 |
| internal organs | 0.5432 |
| PHIL | 0.260793 |
|
CLICK HERE |
| 10415 |
Centers for Disease Control and Prevention |
Html |
en |
Roadmap for State Program Planning - Collect Resources and Data - Define and Document'State Resources'DHDSP'CDC |
null |
| state BRFSS survey | 0.583188 |
| state epidemiologist | 0.508142 |
| Support | 0.417202 |
| vital statistics liaison | 0.573178 |
| stroke signs | 0.583856 |
| State HDSP Plan | 0.600271 |
| state leaders | 0.515793 |
| county level data | 0.582659 |
| national levels | 0.494332 |
| ethnic groups | 0.487733 |
| average age | 0.568418 |
| sample size | 0.491283 |
| tool to— | 0.510985 |
| deaths | 0.417154 |
| hypertension awareness | 0.582355 |
| data sources | 0.505331 |
| risk factors | 0.590966 |
| community groups | 0.500163 |
| comprehensive assessment | 0.49405 |
| BRFSS data trends | 0.589036 |
| decision makers | 0.498355 |
| demographic distribution | 0.49819 |
| hds burden document | 0.910941 |
| symptoms | 0.427155 |
| BRFSS modules | 0.56846 |
|
| HDS data | 0.622027 |
| heart attack | 0.554656 |
| ethnicity | 0.41905 |
| stroke outcomes | 0.543686 |
| prevalence | 0.418819 |
| ways | 0.416833 |
| heart disease | 0.731041 |
| cholesterol awareness | 0.58263 |
| different audiences | 0.500526 |
| public awareness | 0.513539 |
| Disparities | 0.422804 |
| cardiovascular disease | 0.577673 |
| statistically adequate responses | 0.575636 |
| strategies | 0.416952 |
| resources | 0.417182 |
| state level changes | 0.581203 |
| onset | 0.420183 |
| priority populations | 0.727555 |
| interventions | 0.416813 |
| HDSP modules | 0.493857 |
| public health priority | 0.632971 |
| related risk factors | 0.581369 |
| socioeconomic status | 0.501242 |
| stroke prevention | 0.546087 |
|
CLICK HERE |
| 10522 |
Centers for Disease Control and Prevention |
Html |
en |
Email Updates: September 10, 2012'Clinicians Outreach and Communication Activity (COCA) |
CDC Clinician Outreach and Communication Activity (COCA). Providing clinicians the most current and reliable information on emerging public health threats, such as pandemics, natural disasters, and bioterrorism. |
| CDC | 0.79773 |
| Salmonella Braenderup Infections | 0.571051 |
| annual National Preparedness | 0.606126 |
| Public Health Matters | 0.583523 |
| Emergency Preparedness | 0.598236 |
| FDA Safety Information | 0.57715 |
| Nile virus infections | 0.634162 |
| Yosemite National Park | 0.66796 |
| Health Alert Network | 0.578176 |
| CDC Health Advisory | 0.694817 |
| Nile Virus epidemiology | 0.616115 |
| – (CDC) | 0.655555 |
| CDC Science Clips | 0.698141 |
| Additional COCA Conference | 0.595771 |
| Disaster Risk Reduction | 0.576483 |
| state health departments | 0.581669 |
| Cases Sparks Concern | 0.564288 |
| CDC Influenza Division | 0.683735 |
| important safety information | 0.576599 |
| Nile virus exposures | 0.612749 |
| new pharmacy-focused effort | 0.579183 |
| health care providers | 0.58037 |
| Free CE credit/contact | 0.573398 |
| Weekly Flu View | 0.569555 |
| human medical products | 0.566437 |
|
| EID Home Page | 0.574117 |
| preparedness resources | 0.57051 |
| Current Travel Warnings | 0.568746 |
| blood pressure control | 0.579004 |
| CDC Features | 0.704494 |
| Event Reporting Program | 0.567234 |
| CDC Fact Sheet | 0.679327 |
| Human Infections Reported | 0.571355 |
| U.S. Preventive Services | 0.573578 |
| COCA Email Update | 0.600308 |
| west nile virus | 0.920741 |
| public health community | 0.593401 |
| public health | 0.605379 |
| Specific Hazards preparedness | 0.596447 |
| Nile virus season | 0.613649 |
| preparedness message | 0.565239 |
| subject matter expert | 0.577923 |
| in-person training centers | 0.570527 |
| Hantavirus Pulmonary Syndrome | 0.570954 |
| National Park Hantavirus | 0.583021 |
| National Park Service | 0.578412 |
| high blood pressure | 0.578754 |
| weekly influenza surveillance | 0.568507 |
| Response Training Resources | 0.577353 |
|
CLICK HERE |
| 11223 |
Centers for Disease Control and Prevention |
Html |
en |
Los defectos cardiacos denacimiento a lo largo de la vida |
Febrero 7-14: Semana de Concientización sobre los Defectos Cardiacos de Nacimiento. Las personas con estas afecciones ahora viven más tiempo y de manera más saludable. Lea la historia de un hombre que vive con un defecto cardiaco de nacimiento. |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 11368 |
Centers for Disease Control and Prevention |
Html |
en |
Interim Guidance for Environmental Infection Control in Hospitals for Ebola Virus |
null |
| grossly contaminated PPE | 0.623283 |
| waste treatment process | 0.569964 |
| low infectious dose | 0.580485 |
| bloody intravenous insertion | 0.64387 |
| high virus titers | 0.634819 |
| Ebola virus transmission | 0.707096 |
| ebola virus | 0.928538 |
| U.S. Department | 0.571707 |
| nucleic acid amplification | 0.614064 |
| consistent daily cleaning | 0.578555 |
| Control Recommendations | 0.573474 |
| rigid waste receptacle | 0.630203 |
| personal protective equipment | 0.626218 |
| contaminated surfaces | 0.587684 |
| body fluids | 0.574422 |
| Routine cleaning | 0.583118 |
| mucous membrane exposure | 0.570138 |
| disposable cleaning cloths | 0.577936 |
| specific label claims | 0.584051 |
| common non-enveloped viruses | 0.588682 |
| non-enveloped virus | 0.59548 |
| bed rails | 0.575117 |
| United States | 0.569878 |
| Ebola viruses | 0.642475 |
|
| non-enveloped viruses | 0.692762 |
| reusable porous surfaces | 0.579706 |
| U.S. Environmental Protection | 0.580568 |
| potentially contaminated textiles | 0.597704 |
| Hospitalized Patients | 0.579599 |
| Limited laboratory studies | 0.577776 |
| EPA-registered hospital disinfectant | 0.653637 |
| Infection Prevention | 0.57489 |
| virus persistence | 0.579157 |
| Ebola Virus Disease | 0.757112 |
| nonenveloped viruses | 0.587846 |
| Hazardous Materials Regulations | 0.693825 |
| daily cleaning | 0.579801 |
| enveloped virus | 0.613978 |
| nonviable virus | 0.583081 |
| infected blood | 0.573505 |
| environmental services staff | 0.576961 |
| blood-stained glove | 0.577468 |
| label claims | 0.640604 |
| confirmed EVD | 0.618829 |
| PPE doffing area | 0.597778 |
| enveloped RNA viruses | 0.602994 |
| patient care environment | 0.765454 |
| u.s. hospitals | 0.598267 |
|
CLICK HERE |
| 12859 |
Centers for Disease Control and Prevention |
Html |
en |
Community Quarantine to Interrupt Ebola Virus Transmission -Mawah Village, Bong County, Liberia, August-October, 2014 |
Tolbert Nyenswah, MPH1*, David J. Blackley, DrPH2*, Tabeh Freeman, MD3, Kim A. Lindblade, PhD4, Samson K. |
| proposed measures | 0.331293 |
| Ebola treatment unit | 0.719852 |
| effective community quarantine | 0.464312 |
| household quarantine | 0.375545 |
| public health interventions | 0.33475 |
| David J. Blackley | 0.455998 |
| Ebola virus transmission | 0.450766 |
| community quarantine period | 0.45128 |
| local river crossings | 0.338485 |
| District Ebola Task | 0.543899 |
| ebola task force | 0.629186 |
| Community quarantine measures | 0.471749 |
| Ebola virus | 0.642779 |
| Cara N. Halldin | 0.339067 |
| task force | 0.931559 |
| new Ebola infection | 0.50979 |
| Samson K. Arzoaquoi | 0.336608 |
| Bong Mine Town | 0.537512 |
| A. Scott Laney | 0.340222 |
| Kim A. Lindblade | 0.336165 |
| district health authorities | 0.335642 |
| Task Force chair | 0.363628 |
| county health officer | 0.475714 |
| 7Fuamah District Health | 0.3354 |
| basic medical services | 0.328589 |
|
| adult male Mawah | 0.354368 |
| Ebola virus disease | 0.512541 |
| Mawah | 0.440178 |
| community members | 0.352579 |
| local leaders | 0.463164 |
| Ebola virus testing | 0.480503 |
| quarantine period | 0.471664 |
| MMWR
Tolbert Nyenswah | 0.338853 |
| community leaders | 0.387203 |
| Justin N. Williams | 0.334744 |
| Ebola cases | 0.432715 |
| community quarantine | 0.749014 |
| source patient | 0.435976 |
| Bong County | 0.563065 |
| Mawah leaders | 0.334453 |
| Bong County health | 0.467446 |
| village | 0.348184 |
| Global Health Protection | 0.405034 |
| county Ebola task | 0.570095 |
| current Ebola epidemic | 0.44757 |
| medical care | 0.391865 |
| Ebola response | 0.407546 |
| probable Ebola | 0.408713 |
| county health team | 0.388483 |
|
CLICK HERE |
| 13587 |
Centers for Disease Control and Prevention |
Html |
en |
Licensure of a Diphtheria and Tetanus Toxoids and AcellularPertussis Adsorbed and Inactivated Poliovirus Vaccine and Guidancefor Use as a Booster Dose |
Jennifer Liang, DVM1; Greg Wallace, MD2; Gina Mootrey, DO1. |
| Sanofi Pasteur Inc. | 0.60069 |
| earlier dose | 0.466012 |
| Jennifer Liang | 0.433219 |
| American Academy | 0.483367 |
| Gina Mootrey | 0.277979 |
| ACIP liaison organizations | 0.503602 |
| final dose | 0.587873 |
| inactivated poliovirus types | 0.37654 |
| Greg Wallace | 0.267219 |
| inactivated poliovirus | 0.427721 |
| valid final dose | 0.576267 |
| children | 0.274994 |
| U.S. children | 0.260898 |
| Family Physicians | 0.260769 |
| National Center | 0.343805 |
| deltoid muscle | 0.261695 |
| acellular pertussis | 0.324313 |
| Pediatric Nurse Practitioners | 0.375363 |
| dose | 0.83338 |
| pertussis toxoid | 0.288351 |
| tetanus toxoids | 0.446046 |
| Respiratory Diseases | 0.343133 |
| individual antigens | 0.299634 |
| filamentous hemagglutinin | 0.261819 |
| previous dose | 0.458966 |
|
| VAR vaccines | 0.323438 |
| DTaP-IPV vaccine formulations | 0.572339 |
| minimum interval requirements | 0.371769 |
| separately administered DTaP | 0.482677 |
| United States | 0.274652 |
| Quadracel vaccine | 0.771617 |
| Drug Administration | 0.273774 |
| Immunization Practices | 0.282079 |
| Advisory Committee | 0.262389 |
| additional combined diphtheria | 0.432724 |
| previous doses | 0.264563 |
| DTaP vaccines | 0.426642 |
| federal Vaccines | 0.334089 |
| Sanofi Pasteur | 0.995075 |
| DTaP vaccine | 0.441562 |
| IPV series | 0.564063 |
| ACIP Combination Vaccines | 0.579423 |
| National Association | 0.259188 |
| DTaP-IPV vaccine | 0.596732 |
| vaccine | 0.863897 |
| licensed indications | 0.263679 |
| DTaP series | 0.302148 |
| Children Program | 0.265834 |
| work group | 0.415801 |
|
CLICK HERE |
| 15519 |
Centers for Disease Control and Prevention |
Html |
en |
WHO Western Pacific Region (WPR) 2012-2013 |
Overview of the CDC Influenza Division International Program WHO Western Pacific Region (WPR), its objectives and goals, and contains downloadable annual reports on supported countries. |
| influenza | 0.911638 |
| Papua New Guinea | 0.438706 |
| avian influenza | 0.490406 |
| National Influenza Centres | 0.661924 |
| ILI surveillance review | 0.350932 |
| Influenza Centres Laboratory | 0.564329 |
| Influenza cooperative agreements | 0.557514 |
| Western Pacific Region | 0.829732 |
| Global Influenza Surveillance | 0.727418 |
| National Influenza Centers | 0.538791 |
| severe influenza | 0.468088 |
| timely information collection | 0.421942 |
| Support Influenza Vaccine | 0.50267 |
| WPR influenza labs | 0.530594 |
| pandemic influenza | 0.55903 |
| proportion influenza | 0.435859 |
| Region Global Influenza | 0.477982 |
| laboratory-based influenza surveillance | 0.52638 |
| Public Health Advisor | 0.366868 |
| Pacific Regional Office | 0.354856 |
| CDC Influenza Division | 0.520007 |
| pandemic influenza preparedness | 0.494863 |
| seasonal influenza vaccine | 0.51287 |
| Centres Laboratory Staff | 0.362257 |
|
| seasonal influenza vaccines | 0.587261 |
| public health | 0.412474 |
| World Health Organization | 0.393674 |
| Western Pacific Surveillance | 0.382051 |
| seasonal influenza | 0.696442 |
| Laboratory influenza supplies | 0.503588 |
| national level surveillance | 0.441468 |
| Influenza Viruses | 0.536178 |
| Heightened influenza surveillance | 0.536175 |
| National Influenza Centre | 0.513342 |
| national professional officer | 0.428326 |
| domestic influenza vaccine | 0.594324 |
| level surveillance data | 0.415589 |
| infection prevention | 0.363798 |
| influenza vaccine effectiveness | 0.503986 |
| Influenza Division | 0.6529 |
| influenza surveillance | 0.804884 |
| provincial rapid response | 0.357339 |
| Regional Office | 0.401866 |
| influenza vaccine policies | 0.667498 |
| rapid response teams | 0.431061 |
| International Health Regulations | 0.390791 |
| avian influenza specimens | 0.464417 |
|
CLICK HERE |